VEGFA and urinary bladder cancer: For example, miR-34a inhibited angiogenesis in bladder cancer, as assessed by reduced endothelial cell tube formation in vitro and reduced vascular endothelial growth factor (VEGF) expression and CD31+ vessel density within tumors (Yu et al., 2014).